Keyence vs Vertex Pharmaceuticals Incorporated
Vergelijking van marktkapitalisatie in de tijd
Keyence
$130.5B
Rang #137
Vertex Pharmaceuticals Incorporated
$134.0B
Rang #133
Marktkapitalisatie in de tijd
Belangrijke momenten
- Keyence streefde Vertex Pharmaceuticals Incorporated voorbij tegen 2002
- Vertex Pharmaceuticals Incorporated streefde Keyence voorbij tegen 2006
- Keyence streefde Vertex Pharmaceuticals Incorporated voorbij tegen 2007
- Vertex Pharmaceuticals Incorporated streefde Keyence voorbij tegen 2008
- Keyence streefde Vertex Pharmaceuticals Incorporated voorbij tegen 2016
- Vertex Pharmaceuticals Incorporated streefde Keyence voorbij tegen 2023
- Keyence streefde Vertex Pharmaceuticals Incorporated voorbij tegen 2024
- Vertex Pharmaceuticals Incorporated streefde Keyence voorbij tegen 2025
Jaar-op-jaarvergelijking
| Jaar | Keyence | Vertex Pharmaceuticals Incorporated | Koploper |
|---|---|---|---|
| 2026 | $130.5B | $134.0B | Vertex Pharmaceuticals Incorporated |
| 2025 | $91.7B | $115.1B | Vertex Pharmaceuticals Incorporated |
| 2024 | $103.7B | $102.2B | Keyence |
| 2023 | $99.2B | $103.3B | Vertex Pharmaceuticals Incorporated |
| 2022 | $81.7B | $73.3B | Keyence |
| 2021 | $114.3B | $55.7B | Keyence |
| 2020 | $91.4B | $60.0B | Keyence |
| 2019 | $60.3B | $55.6B | Keyence |
| 2018 | $43.5B | $42.1B | Keyence |
| 2017 | $49.2B | $38.0B | Keyence |
| 2016 | $31.2B | $18.7B | Keyence |
| 2015 | $26.0B | $31.9B | Vertex Pharmaceuticals Incorporated |
| 2014 | $20.8B | $30.2B | Vertex Pharmaceuticals Incorporated |
| 2013 | $17.4B | $18.9B | Vertex Pharmaceuticals Incorporated |
| 2012 | $9.2B | $10.6B | Vertex Pharmaceuticals Incorporated |
| 2011 | $6.5B | $8.4B | Vertex Pharmaceuticals Incorporated |
| 2010 | $8.2B | $8.9B | Vertex Pharmaceuticals Incorporated |
| 2009 | $6.7B | $10.9B | Vertex Pharmaceuticals Incorporated |
| 2008 | $5.2B | $7.7B | Vertex Pharmaceuticals Incorporated |
| 2007 | $7.9B | $5.9B | Keyence |
| 2006 | $9.2B | $9.5B | Vertex Pharmaceuticals Incorporated |
| 2005 | $9.5B | $7.0B | Keyence |
| 2004 | $5.4B | $2.7B | Keyence |
| 2003 | $5.3B | $2.6B | Keyence |
| 2002 | $4.8B | $4.0B | Keyence |
| 2001 | $5.1B | $6.2B | Vertex Pharmaceuticals Incorporated |